Biotech & Health

NewLimit, co-founded by Coinbase CEO Brian Armstrong, raises $40M to extend life

Comment

Coinbase Co-founder and CEO Brian Armstrong
Image Credits: Steve Jennings / Getty Images

NewLimit, a 1.5-year-old, San Francisco-based, 17-person company that aims to increase the number of healthy years each person lives by epigenetically reprogramming cells, is today announcing that it has raised $40 million in Series A funding from Dimension, Kleiner Perkins, Founders Fund, and other investors.

We talked with two of the companies’ four co-founders yesterday, including Coinbase CEO Brian Armstrong and VC Blake Byers, who has a Stanford PhD in bioengineering. During that chat, we got more insight into the round, which also counts Coinbase co-founder Fred Ehrsam, Y Combinator President Garry Tan and founder-investor Elad Gil as backers. We talked with them about how NewLimit can differ itself from rival companies. We also asked Armstrong about the inevitable jokes centered on billionaires trying to escape death by throwing money at it.

TC: Brian you have a job as Coinbase CEO. Blake, you have a job running Byers Capital. Who is running NewLimit?

BA: There are four co-founders of the company. I’m really just an investor and a board member. The two other co-founders, Greg [Johnson] and Jacob [Kimmel] are really operating the business day to day.

Are they co-CEOs or is the company bringing on a full-time CEO?

BB: The company doesn’t have a technical full-time CEO right now.

Why is that?

BA: It’s early stage and the current founding team is working really well, so we haven’t defined that yet.

But you’ve now raised $150 million to date, is that right, and are you talking about the valuation of the company at this point?

BB: The $110 million from Brian and myself is a commitment over the lifetime of the company so it’s not fully funded yet, then this $40 million is another commitment from VCs. So we have access to that capital over time, but it’s not necessarily the amount that’s in the bank. We’re not [talking about the valuation].

An earlier news release said that you’re going to start by interrogating epigenetic drivers of aging and developing products that can regenerate tissues to treat specific patient populations. First, just to be clear, what are the specific drivers of aging you’re talking about? Diet? Exercise? Sun damage? Toxins?

BB: There are likely many drivers of aging. And we’re not here trying to elucidate all of them. We’re more saying like, hey, we think that epigenetics alone is a major contributing driver to aging. And so by kind of reprogramming the epigenetics of a cell, you can reverse a significant amount of the functional decline that we see with age. And our proof point of that is you can take an old skin cell from an animal and you’re going to turn that into a newborn animal with an entirely normal life ahead of it. And then you can actually wait for that animal to grow up and be old and take one of its old skin cells and turn that into a newborn animal with an entirely normal life ahead of it, with entirely healthy skin.

There’s actually one lab that did that for more than 13 generations [of mice] over 22 years, just serially, one after the other after the other, all descended from that one parent cell — an old skin cell. And the mice all lived normal lives. We don’t know if this is going to hold up in humans and in different cell types, but it kind of shows you like there’s something very potent and powerful about the ability to just reprogram the skin cell or neuron or the heart cell using epigenetics, even though we’re not tackling what could be other contributing factors to aging.

It brings to mind artificial-egg technology and this idea or hope that even same-sex male couples might be able to have children if we can figure out how to turn any cell into an egg, which has been done with male mice. What exactly is on your roadmap? 

BB: For right now, it’s a very basic, research-stage company. We’re trying to figure out how these mechanisms work and how we can control the epigenetic state of the cells and find these sets of transcription factors that can turn old cells into young cells. So that’s what we’re doing right now before we can make a product, and we’re starting with an immune cell called T cells. The idea is one day if we’re successful, you could make old people’s immune systems younger, and so more functional. We’ll also add some other cell types. We don’t know exactly what those will be yet, but an example would be liver cells, which are called hepatocytes, or brain cells, like neurons, where you could restore function as these cells age.

NewLimit says it will use machine learning models to understand how these cells change with age. How do you develop a moat around something like this, where you’re talking about troves of information about human cells, which is not a proprietary dataset?

BB: I’d say the big difference of developing these general AI models on public data is, like, everyone has access to the public data, including these large language models. For us, we’ve already trained on public data and within two months, our models had saturated how good they were going to be, and now we have to generate the data ourselves to improve the models even further. So a lot of the cost and complexity [centers on] how you generate huge amounts of data in house while still being very efficient.

How exactly are you generating your own data in-house?

BB: We’re generating new scientific data ourselves by running experiments in our lab. What those experiments look like is we insert human transcription factors into human cells like T cells, and then we monitor that cell and to see how it changes after we introduce that transcription factor. It’s called an over-expression experiment. Then we do that with 100 different transcription factors, then with combinations of different transcription factors. And we measure everything we can about the cell, including how it changes the gene expression to the cell and how it changes the epigenetics of the cell. And we use all that information to feed into our machine learning models that then tell us what to test next. So we have a bunch of human immune cells growing in the labs that we’re inserting these transcription factor sets into, and that’s what’s generating the data to train the models.

Where are these donor cells coming from?

BB: T cells you just can get from blood draws, so it’s pretty easy to access these kinds of donor draws.

Are you working with a hospital system?

BB: I don’t want to go into who [the sources] are exactly, but it’s very standard in the industry. There are various groups that help provide blood draws to groups that are working on research projects to make medicines. And it’s all consented donors who are aware of what their specimens are being used for.

Is it possible to explain at what point the data becomes meaningful?

BA: Well, there are something like 1,700 transcription factors in the human body. And so if you were to take how many combinations of five transcription factors there are out of 1,700, it would be about 10 to the 10. So it’s a very large number. You could imagine that as being the search space of different potential combinations. Is that helpful?

To some readers, hopefully! Before letting you both go, Brian, invariably people are going to comment that billionaires keep trying to extend life because they can’t take their billions with them. What’s your reaction?

My high-level thought is that if you’ve made money in software, it’s good to put money back into society in ways that can help improve the human condition, and biotech research is one of those really important areas. I don’t think it gets enough funding. If you look at all the major diseases out there that kill people — heart disease, cancer, diabetes, dementia — they’re highly correlated with aging. Generally speaking, these are not diseases of younger people. So it makes sense to me that we should try to go after big ambitious problems in the world. And I think there’s actually a generation of tech billionaires — Sam Altman, Patrick Collison and a bunch of them — that are putting real capital toward some of these hard problems in the world, and I think that should be celebrated.

One billionaire who thinks anti aging research is dangerous is Elon Musk. He has said it could lead to rapidly aging populations that would lead to further declining birth rates and a very ossified society where new ideas cannot succeed. What do you think about the potential downsides of people living longer?

BA: I think it’s important that if people are going to live longer — which, by the way, that’s a big if; there’s a lot of work ahead of us to see if that is even possible — that their minds remain plastic and they remain open to new ideas and things like that as well. So in an ideal world here in the future, there’s a way for us, our bodies and our minds, to stay young.

BB: I’d also point out like we basically have doubled the average human lifespan over the last 100 years. And I think everyone would agree that’s a good thing. Do we really want to go backwards? Do we think this is actually optimal? Or do we want to keep improving it for people? I think the world is very resilient. It’s a beautiful thing to let people express themselves over longer periods of time and to spend more time with the people who they actually love in life.

More TechCrunch

China has closed a third state-backed investment fund to bolster its semiconductor industry and reduce reliance on other nations, both for using and for manufacturing wafers — prioritizing what is…

China’s $47B semiconductor fund puts chip sovereignty front and center

Apple’s annual list of what it considers the best and most innovative software available on its platform is turning its attention to the little guy.

Apple’s Design Awards nominees highlight indies and startups, largely ignore AI (except for Arc)

The spyware maker’s founder, Bryan Fleming, said pcTattletale is “out of business and completely done,” following a data breach.

Spyware maker pcTattletale shutters after data breach

AI models are always surprising us, not just in what they can do, but what they can’t, and why. An interesting new behavior is both superficial and revealing about these…

AI models have favorite numbers, because they think they’re people

On Friday, Pal Kovacs was listening to the long-awaited new album from rock and metal giants Bring Me The Horizon when he noticed a strange sound at the end of…

Rock band’s hidden hacking-themed website gets hacked

Jan Leike, a leading AI researcher who earlier this month resigned from OpenAI before publicly criticizing the company’s approach to AI safety, has joined OpenAI rival Anthropic to lead a…

Anthropic hires former OpenAI safety lead to head up new team

Welcome to TechCrunch Fintech! This week, we’re looking at the long-term implications of Synapse’s bankruptcy on the fintech sector, Majority’s impressive ARR milestone, and more!  To get a roundup of…

The demise of BaaS fintech Synapse could derail the funding prospects for other startups in the space

YouTube’s free Playables don’t directly challenge the app store model or break Apple’s rules. However, they do compete with the App Store’s free games.

YouTube’s free games catalog ‘Playables’ rolls out to all users

Featured Article

A comprehensive list of 2024 tech layoffs

The tech layoff wave is still going strong in 2024. Following significant workforce reductions in 2022 and 2023, this year has already seen 60,000 job cuts across 254 companies, according to independent layoffs tracker Layoffs.fyi. Companies like Tesla, Amazon, Google, TikTok, Snap and Microsoft have conducted sizable layoffs in the first months of 2024. Smaller-sized…

9 hours ago
A comprehensive list of 2024 tech layoffs

OpenAI has formed a new committee to oversee “critical” safety and security decisions related to the company’s projects and operations. But, in a move that’s sure to raise the ire…

OpenAI’s new safety committee is made up of all insiders

Time is running out for tech enthusiasts and entrepreneurs to secure their early-bird tickets for TechCrunch Disrupt 2024! With only four days left until the May 31 deadline, now is…

Early bird gets the savings — 4 days left for Disrupt sale

AI may not be up to the task of replacing Google Search just yet, but it can be useful in more specific contexts — including handling the drudgery that comes…

Skej’s AI meeting scheduling assistant works like adding an EA to your email

Faircado has built a browser extension that suggests pre-owned alternatives for ecommerce listings.

Faircado raises $3M to nudge people to buy pre-owned goods

Tumblr, the blogging site acquired twice, is launching its “Communities” feature in open beta, the Tumblr Labs division has announced. The feature offers a dedicated space for users to connect…

Tumblr launches its semi-private Communities in open beta

Remittances from workers in the U.S. to their families and friends in Latin America amounted to $155 billion in 2023. With such a huge opportunity, banks, money transfer companies, retailers,…

Félix Pago raises $15.5 million to help Latino workers send money home via WhatsApp

Google said today it’s adding new AI-powered features such as a writing assistant and a wallpaper creator and providing easy access to Gemini chatbot to its Chromebook Plus line of…

Google adds AI-powered features to Chromebook

The dynamic duo behind the Grammy Award–winning music group the Chainsmokers, Alex Pall and Drew Taggart, are set to bring their entrepreneurial expertise to TechCrunch Disrupt 2024. Known for their…

The Chainsmokers light up Disrupt 2024

The deal will give LumApps a big nest egg to make acquisitions and scale its business.

LumApps, the French ‘intranet super app,’ sells majority stake to Bridgepoint in a $650M deal

Featured Article

More neobanks are becoming mobile networks — and Nubank wants a piece of the action

Nubank is taking its first tentative steps into the mobile network realm, as the NYSE-traded Brazilian neobank rolls out an eSIM (embedded SIM) service for travelers. The service will give customers access to 10GB of free roaming internet in more than 40 countries without having to switch out their own existing physical SIM card or…

16 hours ago
More neobanks are becoming mobile networks — and Nubank wants a piece of the action

Infra.Market, an Indian startup that helps construction and real estate firms procure materials, has raised $50M from MARS Unicorn Fund.

MARS doubles down on India’s Infra.Market with new $50M investment

Small operations can lose customers by not offering financing, something the Berlin-based startup wants to change.

Cloover wants to speed solar adoption by helping installers finance new sales

India’s Adani Group is in discussions to venture into digital payments and e-commerce, according to a report.

Adani looks to battle Reliance, Walmart in India’s e-commerce, payments race, report says

Ledger, a French startup mostly known for its secure crypto hardware wallets, has started shipping new wallets nearly 18 months after announcing the latest Ledger Stax devices. The updated wallet…

Ledger starts shipping its high-end hardware crypto wallet

A data protection taskforce that’s spent over a year considering how the European Union’s data protection rulebook applies to OpenAI’s viral chatbot, ChatGPT, reported preliminary conclusions Friday. The top-line takeaway…

EU’s ChatGPT taskforce offers first look at detangling the AI chatbot’s privacy compliance

Here’s a shoutout to LatAm early-stage startup founders! We want YOU to apply for the Startup Battlefield 200 at TechCrunch Disrupt 2024. But you’d better hurry — time is running…

LatAm startups: Apply to Startup Battlefield 200

The countdown to early-bird savings for TechCrunch Disrupt, taking place October 28–30 in San Francisco, continues. You have just five days left to save up to $800 on the price…

5 days left to get your early-bird Disrupt passes

Venture investment into Spanish startups also held up quite well, with €2.2 billion raised across some 850 funding rounds.

Spanish startups reached €100 billion in aggregate value last year

Featured Article

Onyx Motorbikes was in trouble — and then its 37-year-old owner died

James Khatiblou, the owner and CEO of Onyx Motorbikes, was watching his e-bike startup fall apart.  Onyx was being evicted from its warehouse in El Segundo, near Los Angeles. The company’s unpaid bills were stacking up. Its chief operating officer had abruptly resigned. A shipment of around 100 CTY2 dirt bikes from Chinese supplier Suzhou…

1 day ago
Onyx Motorbikes was in trouble — and then its 37-year-old owner died

Featured Article

Iyo thinks its GenAI earbuds can succeed where Humane and Rabbit stumbled

Iyo represents a third form factor in the push to deliver standalone generative AI devices: Bluetooth earbuds.

1 day ago
Iyo thinks its GenAI earbuds can succeed where Humane and Rabbit stumbled

Arati Prabhakar, profiled as part of TechCrunch’s Women in AI series, is director of the White House Office of Science and Technology Policy.

Women in AI: Arati Prabhakar thinks it’s crucial to get AI ‘right’